banner
New Risk Analysis
Welcome.  Sign in or register.
Refer A Friend | Contact Us
Providing investors with the
tools to make informed decisions.
Providing investors with the
tools to make informed decisions.
 Tracking 1027 U.S. listed China Stocks and Counting...
 Tracking 1320 U.S. Stocks and Counting...
Home
Market Activity
Shell Activity
Research
Message Boards
GeoBlog
About
GeoResearchGeoBargainsGeoSpecialsGuidanceMake GoodsPenny StocksRecent AdditionsAll Companies

 China Biologic Products (NASDAQ:CBPO)

GeoProfile
    Overview  
GeoResearch
Message Board
Alerts Log
GeoWire Log
Third party data
Quote
Level II
Historical Prices
Options
Profile
Financials
Charts
News
Filings
Insiders

At least one FIE exists in the corporate structure

Company Description

China Biologic Products, Inc., through its indirect majority-owned subsidiary, Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.

Web site: http://www.ctbb.com.cn/

Last updated March 17, 2008

Home  |   Market Activity  |   Research  |   Message Boards  |   My Account  |   Refer a Friend   |   Contact Us

About  |   Site Map  |   Privacy Policy  |   Terms of Service  |   Twitter  |   © 2009 GeoInvesting LLC


Articles | Asian Stock | Asian Stock Market | Asian Stocks | Business Outlook | Company Analysis | Company Profile
Day Trading | Stock Analysis| Stock Research


Statements and scenarios on GeoInvesting are not intended to be investment advice, but are based on some
commonly used investment guidelines. They are provided to aid investors in making their own investment decisions.
Please review GeoInvesting's complete disclosures and disclaimers under the link above regarding "Terms of Service."